![Naimish Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Naimish Patel
Chief Tech/Sci/R&D Officer at
CRISPR THERAPEUTICS AG
Net worth: 1 M $ as of 30/09/2026
Profile
Dr. Naimish Patel, MD, is a Chief Medical Officer at CRISPR Therapeutics AG.
He is on the Board of Directors at AgomAb Therapeutics NV.
Dr. Patel was previously employed as a Global Head-Dupilumab Program by Sanofi.
He received his undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from McGill University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/05/2026 | 19,357 ( 0.02% ) | 1 M $ | 30/09/2026 |
Naimish Patel active positions
| Companies | Position | Start |
|---|---|---|
| CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | 28/05/2024 |
| AGOMAB THERAPEUTICS NV | Director/Board Member | 11/09/2026 |
Former positions of Naimish Patel
| Companies | Position | End |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
Education of Naimish Patel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
- Stock Market
- Insiders
- Naimish Patel
